Pharmanex赞助的临床试验
总计50个结果
-
PharmanexAspen Clinical Research完全的
-
Fralex TherapeuticsPharmaNet终止
-
Bristol-Myers SquibbPharmaNet完全的
-
Golden Biotechnology CorporationPharmaNet完全的
-
Dr. Reddy's Laboratories LimitedPharmaNet完全的
-
PharmanexUniversity of North Carolina, Chapel Hill完全的
-
Fralex TherapeuticsPharmaNet; McDougall Scientific Limited终止
-
PharmanexUtah State University; Texas Diabetes & Endocrinology, P.A.完全的
-
ShireCovance; PRA Health Sciences; PharmaNet完全的
-
Bristol-Myers SquibbinVentiv Health Clinical; PharmaNet完全的
-
PharmaJet, Inc.United States Department of Defense招聘中
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd完全的
-
Zhe Jiang Hisun Bioray Bio-pharmaceu tical Co.Ltd未知
-
Tata Memorial HospitalPharmanza Herbals Pvt Limited (PHPL)未知
-
Clarus Therapeutics, Inc.Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; PharmaNet完全的
-
PharmaJet, Inc.National Cancer Institute (NCI); National Institutes of Health (NIH)尚未招聘
-
Pharmamel S.L.Instituto de Investigación Hospital Universitario La Paz; Hospital Universitario La Paz完全的
-
AOP Orphan Pharmaceuticals AGGCP-Service International Ltd. & Co. KG; ANOVA CRO s.r.o.; PharmaLex Belgium; Aixial s.r.o.招聘中肺动脉高压奥地利, 西班牙, 法国, 德国, 意大利, 捷克语, 匈牙利, 波兰, 葡萄牙, 罗马尼亚
-
Constantinos HadjipanayisNational Cancer Institute (NCI); NX PharmaGen撤销胶质母细胞瘤 | 脑癌 | 脑部肿瘤 | 脑肿瘤,复发 | 良性肿瘤,脑 | 脑肿瘤,良性 | 脑肿瘤,恶性 | 原发性脑肿瘤 | 颅内肿瘤 | 肿瘤,脑 | 肿瘤,颅内 | 原发性脑肿瘤 | 原发性恶性脑肿瘤 | 原发性恶性脑肿瘤 | 神经胶质瘤美国
-
Jaslok Hospital and Research CentreUniversity of California, Los Angeles; Verdure Sciences; Pharmanza Herbal Pvt Ltd终止
-
Ludwig Institute for Cancer ResearchBoehringer Ingelheim; MedImmune LLC; PharmaJet, Inc.; CureVac; Cancer Research Institute (CRI)完全的
-
PharmaNest, IncIcahn School of Medicine at Mount Sinai; Chinese University of Hong Kong; Imperial College London 和其他合作者尚未招聘